There are no files associated with this item.
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.citation.endPage | 1022 | - |
dc.citation.startPage | 1014 | - |
dc.citation.title | JOURNAL OF COLLOID AND INTERFACE SCIENCE | - |
dc.citation.volume | 649 | - |
dc.contributor.author | Yang, Gyeongseok | - |
dc.contributor.author | Kim, Sangpil | - |
dc.contributor.author | Oh, Jun Yong | - |
dc.contributor.author | Kim, Dohyun | - |
dc.contributor.author | Jin, Seongeon | - |
dc.contributor.author | Choi, Eunshil | - |
dc.contributor.author | Ryu, Ja-Hyoung | - |
dc.date.accessioned | 2023-12-21T11:41:52Z | - |
dc.date.available | 2023-12-21T11:41:52Z | - |
dc.date.created | 2023-07-31 | - |
dc.date.issued | 2023-11 | - |
dc.description.abstract | Targeted delivery along with controlled drug release is considered crucial in development of a drug delivery system (DDS) for efficient cancer treatment. In this paper, we present a strategy to obtain such a DDS by utilizing disulfide-incorporated mesoporous organosilica nanoparticles (MONs), which were engineered to minimize the surface interactions with proteins for better targeting and therapeutic performance. That is, after MONs were loaded with a chemodrug doxorubicin (DOX) through the inner pores, their outer surface was treated for conjugation to the glutathione-S-transferase (GST)-fused cell-specific affibody (Afb) (GST-Afb). These particles exhibited prompt responsivity to the SS bond-dissociating glutathione (GSH), which resulted in considerable degradation of the initial particle morphology and DOX release. As the protein adsorption to the MON surface appeared largely reduced, their targeting ability with GSH-stimulated therapeutic activities was demonstrated in vitro by employing two kinds of the GST-Afb protein, which target human cancer cells with the surface membrane receptor, HER2 or EGFR. Compared with unmodified control particles, the presented results show that our system can significantly enhance cancer-therapeutic outcomes of the loaded drug, offering a promising way of designing a more efficacious DDS. | - |
dc.identifier.bibliographicCitation | JOURNAL OF COLLOID AND INTERFACE SCIENCE, v.649, pp.1014 - 1022 | - |
dc.identifier.doi | 10.1016/j.jcis.2023.06.173 | - |
dc.identifier.issn | 0021-9797 | - |
dc.identifier.scopusid | 2-s2.0-85163825260 | - |
dc.identifier.uri | https://scholarworks.unist.ac.kr/handle/201301/65069 | - |
dc.identifier.wosid | 001027469500001 | - |
dc.language | 영어 | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.title | Surface protein-retractive and redox-degradable mesoporous organosilica nanoparticles for enhanced cancer therapy | - |
dc.type | Article | - |
dc.description.isOpenAccess | FALSE | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Physical | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordAuthor | Mesoporous silica | - |
dc.subject.keywordAuthor | Drug delivery | - |
dc.subject.keywordAuthor | Controlled release | - |
dc.subject.keywordAuthor | Degradation | - |
dc.subject.keywordAuthor | Protein corona | - |
dc.subject.keywordAuthor | Targeted delivery | - |
dc.subject.keywordAuthor | Cancer therapy | - |
dc.subject.keywordPlus | MECHANIZED SILICA NANOPARTICLES | - |
dc.subject.keywordPlus | BIOMOLECULE CORONA | - |
dc.subject.keywordPlus | CONTROLLED-RELEASE | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | CO-DELIVERY | - |
dc.subject.keywordPlus | GATEKEEPERS | - |
dc.subject.keywordPlus | SORAFENIB | - |
dc.subject.keywordPlus | ACID | - |
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Tel : 052-217-1404 / Email : scholarworks@unist.ac.kr
Copyright (c) 2023 by UNIST LIBRARY. All rights reserved.
ScholarWorks@UNIST was established as an OAK Project for the National Library of Korea.